Genotype-phenotype relationship in Iranian patients with cystic fibrosis

In those with the delta F508 mutation, pulmonary involvement and pancreatic insufficiency are more common; the sweat chloride level tended to be higher, but the age at diagnosis was lower, all of which resemble a more severe form of disease.

📌 3 Maddede Bu Makale

🎯

Amaç & Hipotez:Background/Aims: Cystic fibrosis (CF), the most common hereditary, life-threatening disease, is caused by a mu- tation in the CFTR gene.

📊

Temel Bulgular & Veri:Materials and Methods: This case-series study was conducted in 30 patients with CF who were referred to a tertiary pediatric hospital in Tehran.

💡

Sonuç & Katkı:In those with the delta F508 mutation, pulmonary involvement and pancreatic insufficiency are more common; the sweat chloride level tended to be higher, but the age at diagnosis was lower, all of which resemble a more severe form of disease.

🔬Tür:Araştırma Makalesi

📍Kapsam:Genişletilmiş Akademik Örneklem

⚙️Değişkenler:Alan Parametreleri

Özet

Background/Aims: Cystic fibrosis (CF), the most common hereditary, life-threatening disease, is caused by a mu- tation in the CFTR gene. Because different mutations can affect clinical manifestations of patients, this study was conducted to investigate the possible genotype-phenotype relationship in a group of Iranian patients with CF. Materials and Methods: This case-series study was conducted in 30 patients with CF who were referred to a tertiary pediatric hospital in Tehran. In this study, the DNA of the patients was evaluated for delta F508 mutation, whereas some parameters such as the age at diagnosis, the sweat chloride level, and clinical manifestations related to pancreatic insufficiency and pulmonary involvement were also assessed. Results: Among all the studied patients, 16.6% had a delta F508 mutation, either homozygote or heterozygote. The mean age at diagnosis was lower in patients with the delta F508 mutation, but the sweat chloride level tended to be higher in these patients. All the patients with the delta F508 mutation had exocrine pancreatic insufficiency, which tended to be higher than 84% in those without this mutation. In addition, all of these patients had pulmo- nary involvement, which tended to be higher than 64% in those with negative delta F508 mutation. Conclusion: According to the results of this study, the frequency of delta F508 mutations in Iranian patients ap- pears to be much lower than what is seen in American and the European patients. In those with the delta F508 mutation, pulmonary involvement and pancreatic insufficiency are more common; the sweat chloride level tended to be higher, but the age at diagnosis was lower, all of which resemble a more severe form of disease. Keywords:

🔖

Bu Makaleye Atıf Yap

NAJAFİ, M., ALİMADADİ, H., ROUHANİ, P., KİANİ, A. M., KHODADAD, A., MOTAMED, F., MORAVEJİ, A., HOOSHMAND, M., ASHTIANİ, M. T. H., REZAİ, N. (2015). Genotype-phenotype relationship in Iranian patients with cystic fibrosis. Turkish Journal of Gastroenterology, Cilt: 26 - Sayı: 3, 241–243. https://ajindex.com/articles/409385

📄 Tam Metin PDF Okuyucu

Yeni Sekmede Aç ↗

↗Yeni Sekme

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (7)

Kliegman RM, Stanton BF, Geme III JWS, Schor NF. Nelson text- book of pediatrics. 19th ed, Philadelphia, Elsevier Saunders, 2011, pp 1481-97. Cystic Fibrosis Mutation Database (CFMDB). Available at: http:// www.genet.sickkids.on.ca/cftr/StatisticsPage.html, Access date: July 07, 2013.
Kerem E, Kerem B. The relationship between genotype and phe- notype in cystic fibrosis. Curr Opin Pulm Med 1995; 1: 450-6. [CrossRef] Mickle JE, Cutting GR. Genotype-phenotype relationships in cys- tic fibrosis. Med Clin North Am 2000; 84: 597-607. [CrossRef] Jalalirad M, Houshmand M, Mirfakhraie R, Goharbari MH, Mirza- jani F. First study of CF mutations in the CFTR gene of Iranian patients: detection of DeltaF508, G542X, W1282X, A120T, R117H, and R347H mutations. J Trop Pediatr 2004; 50: 359-61. [CrossRef] Alibakhshi R, Zamani M. Mutation analysis of CFTR gene in 70 Iranian cystic fibrosis patients. Iran J Allergy Asthma Immunol 2006; 5: 3-8.
Alibakhshi R, Kianishirazi R, Cassiman JJ, Zamani M, Cuppens H. Anal- ysis of the CFTR gene in Iranian cystic fibrosis patients: identification of eight novel mutations. J Cyst Fibros 2008; 7: 102-9. [CrossRef] Farjadian S, Moghtaderi M, Kashef S, Alyasin S, Najib K, Saki F. Clini- cal and genetic features in patients with cystic fibrosis in south- western iran. Iran J Pediatr 2013; 23: 212-5.
Bonyadi M, Omrani O, Rafeey M, Bilan N. Spectrum of CFTR gene mutations in Iranian Azeri Turkish patients with cystic fibrosis. Genet Test Mol Biomarkers 2011; 15: 89-92. [CrossRef] Fallahi G, Najafi M, Farhmand F, et al. The clinical and laboratory manifestations of Iranian patients with cystic fibrosis. Turk J Pedi- atr 2010; 52: 132-8.
Kerem E, Corey M, Kerem BS, et al. The relation between genotype and phenotype in cystic fibrosis-analysis of the most common mu- tation (delta F508). N Engl J Med 1990; 323: 1517-22. [CrossRef] Campbell PW 3rd, Phillips JA 3rd. The cystic fibrosis gene and rela- tionships to clinical status. Semin Respir Infect 1992; 7: 150-7.
Fekete G, Varadi A, PipirasE, et al. Detection of delta f508 mutation in cyctic fibrosis. Orv Hetil 1992; 133: 2423-30.
Borgo G, Gasparini P, Bonizzato A, Cabrini G, Mastella G, Pignatti PF. Cystic fibrosis: the delta F508 mutation does not lead to an exceptionally severe phenotype. A cohort study. Eur J Pediatr 1993; 152: 1006-11. [CrossRef]